Malaysia, Taiwan say deliveries of Thai-made AstraZeneca vaccines delayed
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
FRIDAY, MAY 20, 2022
FRIDAY, MAY 20, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Malaysia, Taiwan say deliveries of Thai-made AstraZeneca vaccines delayed

Coronavirus chronicle

Reuters
09 June, 2021, 03:55 pm
Last modified: 09 June, 2021, 03:56 pm

Related News

  • US business groups criticize Biden's Taiwan arms sales policy
  • US calls for Taiwan's inclusion at upcoming WHO assembly
  • Malaysia touts trade access as US Indo-Pacific plan only a 'good beginning' -trade chief
  • Indonesia's flip-flops give Malaysia edge in top palm oil market India
  • Malaysia end-April palm oil stocks at five-month high as exports plunge

Malaysia, Taiwan say deliveries of Thai-made AstraZeneca vaccines delayed

The delay comes amid concerns over AstraZeneca's distribution plans in Southeast Asia, which depends on 200 million doses made by Siam Bioscience, a company owned by Thailand's king that is making vaccines for the first time

Reuters
09 June, 2021, 03:55 pm
Last modified: 09 June, 2021, 03:56 pm
A medical worker prepares a dose of Oxford/AstraZeneca's Covid-19 vaccine at a vaccination centre in Antwerp, Belgium March 18, 2021. File Photo:Reuters
A medical worker prepares a dose of Oxford/AstraZeneca's Covid-19 vaccine at a vaccination centre in Antwerp, Belgium March 18, 2021. File Photo:Reuters

Malaysia and Taiwan are expecting deliveries of AstraZeneca Covid-19 vaccines manufactured in Thailand to be delayed, officials said this week, the latest countries to report a holdup with orders from the Thai plant.

The delay comes amid concerns over AstraZeneca's distribution plans in Southeast Asia, which depends on 200 million doses made by Siam Bioscience, a company owned by Thailand's king that is making vaccines for the first time.

Any questions about Siam Bioscience meeting production targets are sensitive because King Maha Vajiralongkorn is its sole owner. Insulting Thailand's monarchy is a crime punishable by up to 15 years in prison.

AstraZeneca handed more than 1.8 million locally produced doses to Thai authorities last week, but said deliveries to other Southeast Asian countries would only begin in July.

The first delivery to the Philippines, which was promised 17 million doses, was reduced and postponed by several weeks, a Philippine presidential adviser told Reuters last week.

Siam Bioscience and AstraZeneca did not immediately respond to requests for comment on Wednesday.

Taiwan's Health Minister Chen Shih-chung told lawmakers on Tuesday that orders from AstraZeneca would be delayed by a month due to production problems at the firm's Thai plant.

Taiwan has ordered 10 million shots directly from the company but has so far only received slightly more than 100,000 doses.

Malaysia, which is due to receive 610,000 doses from Thailand this month and 1.6 million more later this year, is also expecting delays, Science Minister Khairy Jamaluddin told reporters on Wednesday.

Khairy did not specify how long the deliveries would be delayed or how many shipments would be affected.

Malaysia / thailand / Taiwan

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • What needs to be done now?
    What needs to be done now?
  • File photo of Dr Debapriya Bhattacharya. Picture: CPD
    Fiscal consolidation is a way out
  • Safety net needs to be expanded by minimising corruption 
    Safety net needs to be expanded by minimising corruption 

MOST VIEWED

  • Medical staff members check the temperature of people as they enter at Capital Airport, following an outbreak of Covid-19, in Beijing, China, 5 November, 2020. Photo: Reuters
    China relaxes some Covid test rules for US, other travellers
  • Representational image.
    China Junshi's potential Covid drug shows promise in small trial
  • A woman wearing protective mask walks at a sidewalk near business district in Jakarta, Indonesia March 2, 2020. REUTERS/Willy Kurniawan/Files
    Indonesia to drop outdoor mask mandate as Covid-19 infections drop
  • North Korean leader Kim Jong Un presides over a politburo meeting of the ruling Workers' Party, amid the coronavirus disease (COVID-19) pandemic, May 17, 2022, in this photo released May 18, 2022 by North Korea's Korean Central News Agency (KCNA). KCNA via REUTERS
    N Korean leader slams officials' 'immaturity' in response to Covid outbreak
  • North Korea Covid outbreak is 'worrying' for new variants -WHO
    North Korea Covid outbreak is 'worrying' for new variants -WHO
  • People watch a TV broadcasting a news report on the coronavirus disease (Covid-19) outbreak in North Korea, at a railway station in Seoul, South Korea on 17 May 2022. Photo: Reuters.
    N Korea Covid outbreak could have 'devastating' impact on human rights, UN says

Related News

  • US business groups criticize Biden's Taiwan arms sales policy
  • US calls for Taiwan's inclusion at upcoming WHO assembly
  • Malaysia touts trade access as US Indo-Pacific plan only a 'good beginning' -trade chief
  • Indonesia's flip-flops give Malaysia edge in top palm oil market India
  • Malaysia end-April palm oil stocks at five-month high as exports plunge

Features

Sketch: TBS

'Food inflation is an unavoidable consequence of currency devaluation'

16h | Interviews
The open-browser-tabs question also tells an interviewer how much of an internet native the job applicant might be. Photo: Noor-a-Alam

The best question to ask a job applicant

16h | Pursuit
Illustration: TBS

Ugly business: Politics in workplace

15h | Pursuit
Illustration: TBS

‘Do you have insurance?’: Life of a life insurance agent

18h | Panorama

More Videos from TBS

Putin's strategies to face Nato

Putin's strategies to face Nato

5h | Videos
How many countries have nuclear weapons and how many are there?

How many countries have nuclear weapons and how many are there?

5h | Videos
Dengue fever is rising, so beware

Dengue fever is rising, so beware

5h | Videos
How a university teacher and PHD holder become farmer

How a university teacher and PHD holder become farmer

10h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

3
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

4
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

5
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

6
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab